NasdaqCM - Delayed Quote USD
ZyVersa Therapeutics, Inc. (ZVSA)
0.5712
-0.1136
(-16.59%)
At close: May 8 at 4:00:00 PM EDT
0.5799
+0.01
+(1.52%)
After hours: May 8 at 7:56:29 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-7,559.6970
-7,559.6970
-8,720.8190
-1,494.6410
-5,076.0890
Financing Cash Flow
5,952.9470
5,952.9470
5,956.2940
1,865.3840
5,230
End Cash Position
1,530.9240
1,530.9240
3,137.6740
699.3240
328.5810
Issuance of Capital Stock
0
0
18,114.1930
1,964.5240
0
Issuance of Debt
0
--
--
0
5,230
Repurchase of Capital Stock
0
0
-10,702.7790
0
--
Free Cash Flow
-7,559.6970
-7,559.6970
-8,720.8190
-1,494.6410
-5,076.0890
12/31/2021 - 2/11/2022
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
TOVX Theriva Biologics, Inc.
0.6432
-20.59%
SPRC SciSparc Ltd.
0.3500
+12.90%
GLMD Galmed Pharmaceuticals Ltd.
1.2500
-3.10%
KTTA Pasithea Therapeutics Corp.
0.9600
-15.04%
HEPA Hepion Pharmaceuticals, Inc.
0.3940
+1.03%
ADIL Adial Pharmaceuticals, Inc.
0.6200
-4.85%
IBO Impact BioMedical Inc.
0.4975
-2.49%
CAMP CAMP4 THERAPEUTICS CORPORATION
2.1400
-2.28%
PHIO Phio Pharmaceuticals Corp.
1.8000
-11.76%
NCNA NuCana plc
0.1029
-65.83%